Send to

Choose Destination
J Clin Gastroenterol. 2013 Jul;47 Suppl:S7-10. doi: 10.1097/MCG.0b013e31827f0d3d.

The role of imaging in hepatocellular carcinoma: the present and future.

Author information

Department of Radiology, Yale University School of Medicine, New Haven, CT 06520-8042, USA.


Imaging plays an important role in diagnosis and management of patients with hepatocellular carcinoma (HCC). Although ultrasound is the main surveillance imaging tool for HCC, dynamic contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) are used primarily for diagnosis and staging of HCC. Recent advances in both CT and MRI technology have led to a decrease in ionizing radiation exposure and improved capabilities for evaluation of HCC, including, dynamic contrast-enhanced CT and MRI, perfusion CT and MRI, dual-energy CT, radiation dose reduction strategies, diffusion-weighted imaging, MR elastography, iron and fat quantification, and intravenous hepatobiliary contrast agents.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center